305 related articles for article (PubMed ID: 11953332)
1. New steroids and new salicylates in inflammatory bowel disease: a critical appraisal.
Campieri M
Gut; 2002 May; 50 Suppl 3(Suppl 3):III43-6. PubMed ID: 11953332
[TBL] [Abstract][Full Text] [Related]
2. Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's disease.
Fascì Spurio F; Aratari A; Margagnoni G; Doddato MT; Chiesara F; Papi C
Curr Clin Pharmacol; 2012 May; 7(2):131-6. PubMed ID: 22432845
[TBL] [Abstract][Full Text] [Related]
3. Oral locally active steroids in inflammatory bowel disease.
Nunes T; Barreiro-de Acosta M; Marin-Jiménez I; Nos P; Sans M
J Crohns Colitis; 2013 Apr; 7(3):183-91. PubMed ID: 22784947
[TBL] [Abstract][Full Text] [Related]
4. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
5. A practical guide to the management of distal ulcerative colitis.
Ardizzone S; Bianchi Porro G
Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
[TBL] [Abstract][Full Text] [Related]
6. New steroids for IBD: progress report.
Hanauer SB
Gut; 2002 Aug; 51(2):182-3. PubMed ID: 12117876
[No Abstract] [Full Text] [Related]
7. Current status of drug therapy for inflammatory bowel disease.
Peppercorn MA
Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic efficacy of 5-ASA molecules in idiopathic intestinal inflammatory diseases: critical review].
Van Gossum A
Acta Gastroenterol Belg; 1992; 55(5-6):462-71. PubMed ID: 1363167
[TBL] [Abstract][Full Text] [Related]
9. [Budesonide and inflammatory bowel disease].
Gomollón F; Hinojosa J; Nos P
Gastroenterol Hepatol; 1999 Dec; 22(10):525-32. PubMed ID: 10650668
[No Abstract] [Full Text] [Related]
10. New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
Chande N; Marshall JK; Seow CH; Sandborn WJ; Parker CE; Nelson S; Feagan BG
Inflamm Bowel Dis; 2015 Dec; 21(12):2948-57. PubMed ID: 26540276
[TBL] [Abstract][Full Text] [Related]
11. Indoleamine 2,3-dioxygenase expression in human inflammatory bowel disease.
Zhou L; Chen H; Wen Q; Zhang Y
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):695-701. PubMed ID: 22387885
[TBL] [Abstract][Full Text] [Related]
12. The drug therapy of ulcerative colitis and of Crohn's disease.
Tumen HJ
Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770
[No Abstract] [Full Text] [Related]
13. Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease.
van Hees PA
Acta Gastroenterol Belg; 1987; 50(5):555-9. PubMed ID: 2902723
[No Abstract] [Full Text] [Related]
14. Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
Coward S; Kuenzig ME; Hazlewood G; Clement F; McBrien K; Holmes R; Panaccione R; Ghosh S; Seow CH; Rezaie A; Kaplan GG
Inflamm Bowel Dis; 2017 Mar; 23(3):461-472. PubMed ID: 28146003
[TBL] [Abstract][Full Text] [Related]
15. Salicylates for inflammatory bowel disease.
Travis SP; Jewell DP
Baillieres Clin Gastroenterol; 1994 Jun; 8(2):203-31. PubMed ID: 7949456
[TBL] [Abstract][Full Text] [Related]
16. Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.
Kjeldsen J; Lassen JF; Brandslund I; Schaffalitzky de Muckadell OB
Scand J Gastroenterol; 1998 Jun; 33(6):637-43. PubMed ID: 9669637
[TBL] [Abstract][Full Text] [Related]
17. New treatments in inflammatory bowel disease.
Cole AT; Hawkey CJ
Br J Hosp Med; 1992 Apr 15-May 5; 47(8):581-90. PubMed ID: 1591558
[TBL] [Abstract][Full Text] [Related]
18. Review article: Drug development in inflammatory bowel disease: budesonide--a model of targeted therapy.
Hamedani R; Feldman RD; Feagan BG
Aliment Pharmacol Ther; 1997 Dec; 11 Suppl 3():98-107; discussion 107-8. PubMed ID: 9467984
[TBL] [Abstract][Full Text] [Related]
19. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
[No Abstract] [Full Text] [Related]
20. [Conservative therapy of inflammatory bowel diseases].
Nagy F
Orv Hetil; 2002 Dec; 143(50):2763-8. PubMed ID: 12583315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
